HEALTH CATALYST INC (HCAT) Stock Analyst Earnings Estimates
NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 241.9M 28.13% | 276.2M 14.18% | 295.938M 7.15% | 312.69M 5.66% | 343.64M 9.90% | 377.85M 9.96% | |
| EBITDA YoY % growth | -78.27M -4.82% | -86.8M -10.90% | -44.735M 48.46% | 26.537M 159.32% | 40.247M 51.66% | 53.775M 33.61% | |
| EBIT YoY % growth | -115.8M -23.98% | -135.1M -16.67% | -86.958M 35.63% | -66.406M 23.63% | -44.898M 32.39% | -33.383M 25.65% | |
| Operating Margin | -47.87% | -48.91% | -29.38% | -21.24% | -13.07% | -8.84% | |
| EPS YoY % growth | -0.43 36.76% | -0.27 37.21% | 0.15 155.56% | 0.31 109.96% | 0.38 20.34% | 0.52 38.43% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.08 276.99% | 0.07 44.84% | 0.08 -29.17% | 0.09 26.41% | 0.11 47.12% | 0.13 76.06% | 0.15 77.01% | 0.15 72.91% | 0.17 49.43% |
| Revenue Q2Q % growth | 81.261M 8.23% | 83.632M 11.92% | 85.485M 12.63% | 86.357M 13.10% | 89.981M 10.73% | 93.364M 11.64% | 94.928M 11.05% | 96.066M 11.24% | 100.25M 11.41% |
| EBITDA Q2Q % growth | 7.989M -60.57% | 8.991M 220.51% | 9.853M 8.50% | 9.063M -52.21% | 11.765M 47.26% | 12.625M 40.42% | 13.946M 41.54% | 13.195M 45.59% | 14.774M 25.58% |
| EBIT Q2Q % growth | -13.005M 40.79% | -12.298M 31.63% | -10.911M 9.83% | -10.793M 11.54% | -9.037M 30.51% | -7.69M 37.47% | -6.283M 42.42% | -6.201M 42.55% | -5.594M 38.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.07 133.33% | 0.10 | -0.03 | -29.75% |
| Q2 2024 Q2Q % growth | 0.12 140.00% | 0.08 | 0.04 | 48.34% |
| Q1 2024 Q2Q % growth | 0.05 | 0.03 | 0.02 | 75.51% |
| Q4 2023 Q2Q % growth | 0.02 140.00% | 0.00 | 0.02 | 2,661.67% |
| Q3 2023 Q2Q % growth | 0.03 123.08% | -0.02 | 0.05 | 272.20% |
| Q2 2023 Q2Q % growth | 0.05 266.67% | 0.00 | 0.05 | 1,421.28% |
| Q1 2023 Q2Q % growth | 0.05 183.33% | -0.04 | 0.09 | 220.47% |
| Q4 2022 Q2Q % growth | -0.05 73.68% | -0.12 | 0.07 | 56.62% |
| Q3 2022 Q2Q % growth | -0.13 27.78% | -0.20 | 0.07 | 34.12% |
| Q2 2022 Q2Q % growth | -0.03 | -0.10 | 0.07 | 70.83% |
| Q1 2022 Q2Q % growth | -0.06 | -0.12 | 0.06 | 48.65% |
| Q4 2021 Q2Q % growth | -0.19 -18.75% | -0.22 | 0.03 | 12.01% |
| Q3 2021 Q2Q % growth | -0.18 14.29% | -0.22 | 0.04 | 18.81% |
| Q2 2021 Q2Q % growth | 0.00 100.00% | -0.14 | 0.14 | 100.00% |
| Q1 2021 Q2Q % growth | -0.06 62.50% | -0.15 | 0.09 | 60.03% |
| Q4 2020 Q2Q % growth | -0.16 23.81% | -0.20 | 0.04 | 18.72% |
| Q3 2020 Q2Q % growth | -0.21 22.22% | -0.27 | 0.06 | 23.40% |
| Q2 2020 Q2Q % growth | -0.15 28.57% | -0.23 | 0.08 | 34.05% |
| Q1 2020 Q2Q % growth | -0.16 | -0.26 | 0.10 | 38.08% |
| Q4 2019 Q2Q % growth | -0.21 | -0.30 | 0.09 | 29.01% |
| Q3 2019 Q2Q % growth | -0.27 | -0.38 | 0.11 | 28.46% |
| Q2 2019 Q2Q % growth | -0.21 | -0.31 | 0.10 | 32.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 76.353M 3.50% | 77.827M | -1.474M | -1.89% |
| Q2 2024 Q2Q % growth | 75.902M 3.67% | 76.505M | -603K | -0.79% |
| Q1 2024 Q2Q % growth | 74.723M 1.16% | 76.298M | -1.575M | -2.06% |
| Q4 2023 Q2Q % growth | 75.084M 8.57% | 75.076M | 8K | 0.01% |
| Q3 2023 Q2Q % growth | 73.773M 7.93% | 74.117M | -344K | -0.46% |
| Q2 2023 Q2Q % growth | 73.213M 3.66% | 74.087M | -874K | -1.18% |
| Q1 2023 Q2Q % growth | 73.868M 8.49% | 72.669M | 1.199M | 1.65% |
| Q4 2022 Q2Q % growth | 69.16M 6.86% | 69.621M | -461K | -0.66% |
| Q3 2022 Q2Q % growth | 68.35M 10.71% | 68.13M | 220K | 0.32% |
| Q2 2022 Q2Q % growth | 70.63M 18.45% | 71.265M | -635K | -0.89% |
| Q1 2022 Q2Q % growth | 68.09M 21.92% | 67.345M | 745K | 1.11% |
| Q4 2021 Q2Q % growth | 64.72M 21.47% | 64.408M | 312K | 0.48% |
| Q3 2021 Q2Q % growth | 61.74M 30.83% | 62.025M | -285K | -0.46% |
| Q2 2021 Q2Q % growth | 59.63M 37.84% | 57.908M | 1.722M | 2.97% |
| Q1 2021 Q2Q % growth | 55.85M 23.78% | 55.506M | 344K | 0.62% |
| Q4 2020 Q2Q % growth | 53.28M 22.48% | 53.163M | 117K | 0.22% |
| Q3 2020 Q2Q % growth | 47.19M 19.71% | 45.485M | 1.705M | 3.75% |
| Q2 2020 Q2Q % growth | 43.26M 17.55% | 42.98M | 280K | 0.65% |
| Q1 2020 Q2Q % growth | 45.12M 28.15% | 44.339M | 781K | 1.76% |
| Q4 2019 Q2Q % growth | 43.5M | 42.54M | 960K | 2.26% |
| Q3 2019 Q2Q % growth | 39.42M | 38.469M | 951K | 2.47% |
| Q2 2019 Q2Q % growth | 36.8M | 37.208M | -408K | -1.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.8% | -13.69% | -0.2% | -11.6% |
| Revenue | -1.2% | -1.22% | -0.16% | -0.29% |